Form 4 for WGS GeneDx Holdings Corp.
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-09 · accession 0001415889-24-016351 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-11 | 2024-06-09 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,546 | 82.4K | +9% | $0 |
| D | 2024-06-11 | 2024-06-10 | WGS | Stueland Katherine | CEO, Dir | S - Sale+OE | $24.92 | -2,652 | 79.8K | -3% | -$66.1K |
| D | 2024-06-11 | 2024-06-09 | WGS | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | -6,546 | 65.5K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-06-09 | M | A | 6,546 | $0.00 | 82,415 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Common | Class A Common Stock | 2024-06-10 | S | D | 2,652 | $24.92 | 79,763 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-06-09 | M | D | 6,546 | $0.00 | 65,465 | D | — · — to — | 6,546 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |